1. A review of glucagon‐like peptide‐1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus. Issue 12 (11th July 2017) Authors: Owens, David R.; Monnier, Louis; Hanefeld, Markolf Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 12(2017) Page Start: 1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acarbose revisited for efficacy, safety and cardiovascular benefits: a key role for controlling glycemic variability. Issue 4 (July 2012) Authors: Hanefeld, Markolf Journal: Expert review of endocrinology & metabolism Issue: Volume 7:Issue 4(2012) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acarbose revisited for efficacy, safety and cardiovascular benefits: a key role for controlling glycemic variability. Issue 4 (July 2012) Authors: Hanefeld, Markolf Journal: Expert review of endocrinology & metabolism Issue: Volume 7:Issue 4(2012) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Acarbose: oral antidiabetes drug with additional cardiovascular benefits. (February 2008) Authors: Hanefeld, Markolf; Schaper, Frank Journal: Expert review of cardiovascular therapy Issue: Volume 6:Number 2(2008) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies. (July 2013) Authors: Forst, Thomas; Hanefeld, Markolf; Jacob, Stephan; Moeser, Guido; Schwenk, Gero; Pfützner, Andreas; Haupt, Axel Journal: Diabetes & vascular disease research Issue: Volume 10:Number 4(2013) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Issue 1 (14th July 2017) Authors: Gerstein, Hertzel C.; Colhoun, Helen M.; Dagenais, Gilles R.; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Riddle, Matthew C.; Rydén, Lars; Xavier, Denis; Atisso, Charles M.; Avezum, Alvaro; Basile, Jan; Chung, Namsik; Conget, Ignacio; Cushman, William C.; Franek, Edward; Han... Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 1(2018) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects. (March 2014) Authors: Hanefeld, Markolf; Sulk, Stefan; Helbig, Matthias; Thomas, Andreas; Köhler, Carsta Journal: Journal of diabetes science and technology Issue: Volume 8:Number 2(2014:Mar.) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019) Authors: Gerstein, Hertzel C; Colhoun, Helen M; Dagenais, Gilles R; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Riesmeyer, Jeffrey S; Riddle, Matthew C; Rydén, Lars; Xavier, Denis; Atisso, Charles Messan; Dyal, Leanne; Hall, Stephanie; Rao-Melacini, Purnima; Wong, Gloria; Avezum, Alv... Journal: Lancet Issue: Volume 394:Issue 10193(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019) Authors: Gerstein, Hertzel C; Colhoun, Helen M; Dagenais, Gilles R; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Riesmeyer, Jeffrey S; Riddle, Matthew C; Rydén, Lars; Xavier, Denis; Atisso, Charles Messan; Dyal, Leanne; Hall, Stephanie; Rao-Melacini, Purnima; Wong, Gloria; Avezum, Alv... Journal: Lancet Issue: Volume 394:Issue 10193(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Issue 10193 (13th July 2019) Authors: Gerstein, Hertzel C; Colhoun, Helen M; Dagenais, Gilles R; Diaz, Rafael; Lakshmanan, Mark; Pais, Prem; Probstfield, Jeffrey; Botros, Fady T; Riddle, Matthew C; Rydén, Lars; Xavier, Denis; Atisso, Charles Messan; Dyal, Leanne; Hall, Stephanie; Rao-Melacini, Purnima; Wong, Gloria; Avezum, Alvaro; B... Journal: Lancet Issue: Volume 394:Issue 10193(2019) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗